Sentence examples for classes of glucose from inspiring English sources
Three classes of glucose transporters have been described in humans that form different phylogenetic clusters [ 9].
Three classes of glucose transporter can be identified, separating GLUT1-4 and 14, GLUT6, 8, 10 and 12; and GLUT5, 7, 9 and 11.
Sex distribution was not different among the five classes of glucose tolerance (NGT, IFG, IGT, newly detected diabetes, and known diabetes).
Dipeptidyl peptidase-4 (DPP-4) inhibitors are one of the latest therapeutic classes of glucose-lowering medications.
GRADE is a comparative effectiveness study that aims to compare four major classes of glucose-lowering medications in relatively recently diagnosed T2DM patients treated with metformin.
One potential advantage of SGLT-2 inhibition compared with other classes of glucose-lowering therapies relates to the low potential of this class to induce hypoglycaemia, unless combined with insulin or an insulin secretagogue.
Finally, in the past two decades, the diabetes epidemic has spurred the development of eight new classes of glucose-lowering medications that may allow for more effective control of glycemia in T2DM and, thus, reduce complications (14).
It is important that changes in LDL2 and LDL4 were also independent of the use of specific classes of glucose-lowering medications, including insulin or rosiglitazone, that previously were shown to increase LDL particle size (18– 24, 28, 28).
The ACCORD study solely included patients at high risk for cardiovascular disease, in whom low A1C levels were reached by using up to four or five different classes of glucose-lowering drugs.
The UKPDS compared three classes of glucose-lowering medications (sulfonylurea, metformin, or insulin) but was unable to demonstrate clear superiority of any one drug over the others with regard to diabetes complications (6, 7).
The development of new classes of glucose-lowering medications, including in particular the incretin-based therapies, provides an opportunity to utilize combinations of medications which target multiple physiologic abnormalities in type 2 diabetes.
